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Last summer marked the 6-year
anniversary of our partnership with Eli
Lilly and Company to bring you our
collaborative newsletter, Prescriptions for
Excellence in Health Care (PEHC). This
issue is the first in a series devoted to an
extremely important but often overlooked
and underappreciated element in the
process of transforming US health care
– the critical role of hospital boards in
ensuring the quality of care.
Before 2000, quality and safety were largely
missing from hospital board agendas, if
they were discussed at all. With the nation’s
slow but steady push toward transparency
and accountability in health care, things
are beginning to change for the better at
the governing board level. However, we
still have a long way to go to understand
how the definition of quality has changed
in this new era of accountable, integrated
care (ie, identifying the short- and longterm implications for board responsibility,
determining how best to design and deliver
appropriate training for board members).

This newsletter was jointly developed and
subject to editorial review by Jefferson
School of Population Health and Lilly
USA, LLC, and is supported through
funding by Lilly USA, LLC. The content
and viewpoints expressed are those of the
individual authors, and are not necessarily
those of Lilly USA, LLC or the Jefferson
School of Population Health.

If you are at all skeptical about the
importance of the topic, consider this.
Currently, the boards of over 5000
community hospitals in this country

are populated largely by businesspeople
(eg, the local car dealer), philanthropists,
religious leaders, and local politicians. All
of them make a huge time commitment,
most serve without pay, and - whether
they fully realize it or not - all are at
personal risk for fulfilling the fiduciary
responsibilities of their organizations.
With the advent of pay for performance,
hospitals are now at financial risk if
they fail to meet specific quality metrics
around “never” events (eg, wrong site
surgery, readmission for heart failure
within 30 days of discharge). Good
governance dictates that clinicians
cannot be held solely responsible for
a hospital’s quality and safety record.
Counterintuitive as it may seem, the
nonclinical members of the governing
board bear responsibility for the hospital’s
clinical outcomes. That being said, we
Prescriptions for Excellence in Health
Care is brought to Population Health
Matters readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.

(continued on page 2)
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determined that the timing was right
for an in-depth discussion.
We set the stage for the series with
a high-level overview of governance,
“The Future of Board Governance:
The Board as a Mosaic of Talent,” an
engaging account of where we’ve been
and where we’re going from a “30,000foot” perspective.
The second article, “The Board’s
Role in Quality and Patient Safety,”
offers a comprehensive summary
that explains the rationale for board
involvement, discusses the evolving
definition of quality, and hones in on
the various levers, tactics, and tasks for
ensuring success. Next, we drill down

With the Affordable Care Act firmly
in place and the Accountable Care
Organization (ACO) model gaining
traction, the final article, “Pioneering at
the Trust Frontier: The Expanded Role
of Governance in ACOs,” takes a look at
the complexities of multiorganization
boards and the additional oversight
challenges they pose.

The Governance Institute (www.
governanceinstitute.com) has developed
a variety of resources and tools to help
equip boards for success. Among their
offerings are regular regional leadership
conferences. The complete schedule of
programs is available on their Web site
at http://www.governanceinstitute.com/
Conferences/ConferenceCalendar/
tabid/79/Default.aspx. On February
10, 2013, I will be coleading a
preconference education session at the
Governance Institute’s Winter Meeting
in Palm Beach, Florida, and encourage
interested readers to attend.

To date, there are no “how-to”
textbooks or programs that cover this
topic. However, an organization called

As always, I look forward to hearing
from our readers. I can be reached at:
david.nash@jefferson.edu.

a little further into some essential
elements for good governance in an
aptly titled article, “The Journey to
Better Governance: Board Education,
Competencies, and Self-Assessment.”

The Future of Board Governance: The Board as a Mosaic of Talent
By James Kristie
Over the past 3 decades, the public
company board of directors has evolved
from a board composed of friends, family,
and social and business acquaintances
of the chief executive officer (CEO) to
a board now dominated by independent
members who have no unduly close ties
to the top management of the company.
It is a board that has gone from being
what is derogatorily referred to as an
“old boys’ club” to a board that is a being
remolded to be a “mosaic of talent”:
each member selected for a specific
background or skill set that he or she can
bring to complement the overall mix of
expertise sitting around the board table.
This review provides a basis for
projecting how the future of board
governance, specifically in terms of
board composition, will continue to
unfold. To the extent that there is a
“spillover effect” of corporate practices

being adopted into the not-forprofit sector — a trend recognized by
Jefferson School of Population Health
Dean David B. Nash in his coauthored
(with Sean Patrick Murphy and Anne
D. Mullaney) article, “Governance:
Current Trends in Board Education,
Competencies, and Qualifications”1
— the forces that caused a rethinking
and remaking of public company
board membership are worthy of close
attention by leaders of private and notfor-profit health care institutions. To see
how this evolution has played out, here
are a few key milestones of change.
The 1970s
The Securities and Exchange
Commission began a bully-pulpit
campaign for a more independent
board. An ideal board, in its view,
would be one composed entirely
of independent directors, with the

chairman and CEO roles separated.
Other developments at work:
•N
 ominating committees were
being formed as a separate and
distinct formal board committee.
General Motors (GM) had one
of the first when it established its
committee in 1972.
•W
 omen began to enter the
boardroom in growing numbers.
Pfizer, for example, added the first
woman to the board in 1976.
•T
 he stock exchanges began to take
the concept of an independent
board more seriously. In fact,
the New York Stock Exchange
threatened to delist Johnson &
Johnson in 1978 unless it added
the first independent directors to
its board.
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The 1980s
Building on this initial momentum
for a less management-dominated
and insider-populated board, these 3
developments advanced that evolution:
1. Corporate takeovers: With many
companies still operating as
conglomerates of unrelated
businesses, their stock prices
often sold at far below breakup
calculations. Raiders such as T.
Boone Pickens and Carl Icahn
took notice and began preying
on such “mispriced” companies.
Shareholders started paying
attention to how boards handled
the transactional deal making.
2. Activist courts: Precedent-setting
decisions, frequently an outcome of
bungled Merger and Acquisition
behavior by boards, were issued by
the influential Delaware Chancery
and Supreme Courts, pointing to the
need for directors to be much more
diligent about their fiduciary duties.
3. Rise of the institutional investor:
With the big bull market that started
in 1982 and the huge inflows of
funds into new retirement vehicles
such as individual retirement
accounts, institutional investors
began owning larger percentages
of company stock. Proxy voting
became a tool for shareholders
to more aggressively assert their
ownership rights when unhappy
with management and the board.
The 1990s
As we entered the 1990s, shareholders
were more vocal and had more muscle
to push back on boards, as did boards
on management. What happened then?
•W
 hen corporate performance faltered,
boards were less willing to sit idly by:

A bevy of CEOs began to get the
boot. In 1 year alone (1993) the
CEOs of IBM, American Express,
Westinghouse Electric, and
Kodak all were fired by “suddenly
emboldened” boards.
•B
 oards formally codified their roles
and responsibilities: This move
was inspired by the board of GM,
which in 1994 issued a set of 28
governance principles that laid out
for all the world to see how the
GM board would conduct itself
—from determining the board
meeting agenda to how it would
select new board members.
•R
 ise of the lead director: A new
position began appearing in
boardrooms — a single member
designated to be the leader of the
independent directors on boards
that lacked a separation of the chair
and CEO.
The 2000s
Two historic pieces of legislation further
solidified the professionalism of boards:
•D
 espite having a highly credentialed
board, the Houston-based energy
company Enron collapsed almost
overnight into bankruptcy in 2001,
and the next year Congress unleashed
Sarbanes-Oxley. The law mandated
that a board have a “financial expert”
among its members, an important
precedent highlighting the need for a
specific skill set on the board.
•T
 he Great Recession provoked
the Dodd-Frank Act, signed
into law in 2010. One provision,
again pertinent to this analysis,
is that boards now must codify
their policy on board diversity and
enumerate the qualifications of
their board members.

3

What the Future Holds
Looking to the future after this 30year sequence of initiatives for boards
to become more independent, the big
issue is, “How can boards get smarter
about the organizations they govern?”
In recruiting a new director, the
prevailing marching order no longer is
to “get the best person available.” That
was how it was done when I entered
the field 30 years ago. Today, boards
follow a different script: “What’s
missing on our board . . . and let’s find
the right person to fill that gap.”
So what recruiting trends can we
expect to see that will make boards
more knowledgeable and skilled
overseers of their organizations? Here
are 5 prime trends:
1. F
 ewer CEOs, more senior executives:
For decades, getting a “sitting
CEO” has been the gold standard
for a new board member. But
CEOs, fearing the liability and
time commitment required, are
cutting back dramatically on the
number of outside corporate boards
they will take on. Plus, their own
company boards are restricting
them from outside board service.
Up-and-coming senior officers are
prime candidates. This is seen as
a career-enhancing step for them,
so the expectation is that they will
be more diligent in taking their
oversight role seriously.
2. G
 reater gender diversity: Women
represent about 16% of the
membership of Fortune 500 boards,
a number that has not moved
much in a decade. With board
quotas catching on in Europe,
there is a “gathering storm” of
women’s organizations here in the
United States pushing for greater
participation of women on boards.
(continued on page 4)
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Fueling the movement is a growing
body of literature that links higher
performance of companies with
greater representation of women on
their boards.2
3. Age diversity: With 62 as the average
age of a corporate director, attention
is being focused on the “graying” of
corporate boards as a governance
weakness.3 Expect to see a younger
cohort advance into the boardroom
to reflect the information age and
the rapidity of technological change.
4. The “social” director: In 2011,
Starbucks Corp. added to its board
a 29-year-old CEO of a social
media company. That action riveted
attention in the governance world.
One top recruiting firm confided
that as of April 2012 it had 40 open
searches under way for directors
with social media expertise.

5. Other in-demand skill sets:
Desired directors will include:
senior human resource officers
to help boards with talent
management and compensation
oversight issues; health care
executives to help boards with
health care delivery and cost
management issues; and executives
with legal backgrounds, such as
retired general counsels, to help
boards meet their expanding
compliance responsibilities.
The Mosaic of Talent
This set of broad brushstrokes
shows how corporate boards have
professionalized their membership over
the past 30 years, moving decisively
from a “who’s available?” to a “who
do we need?” imperative in recruiting
new members. Corporate America
has gone from a look-alike, thinkalike board to a board as a mosaic of

individuals with diverse but additive
expertise, strengths, personalities, and
backgrounds as well as ages and sexes.
Some of these forces have already,
or may yet, exert themselves in the
remaking of health care institution
boards for an era of profound changes
to their missions and businesses.
James Kristie is editor and associate
publisher of Directors & Boards, a
quarterly journal devoted to corporate
governance. He can be reached at:
jkristie@directorsandboards.com
References
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The Board’s Role in Quality and Patient Safety
By Evan M. Benjamin, MD, FACP
Governing boards have come a long
way in comprehending and accepting
their roles in and responsibilities for
quality and patient safety. In addition
to grasping and navigating the
organization’s financial health, boards
now realize that it is necessary to
comprehend the quality of health care
delivered by their organizations.
Over the past decade, progress made
in the science of improvement, and
increased national attention on
improving population health, have
created the imperative for boards to not
only comprehend quality and safety but
also to focus attention on the important

work of improving value for their
patients. Governing boards must have
in-depth knowledge of the challenges
of providing reliable care, the role of
systems in health care settings, the
existing waste and redundancy in health
care systems that may lead to significant
geographic variation in health care costs,
and the significant amount of harm that
still is produced within the health care
environment today.
A Bit of History
To better appreciate the needs of
governing bodies, it is important to
understand the history of governing
boards of health care organizations.

In 1965, a landmark legal decision
in the case of Darling vs. Charleston
Community Memorial Hospital
placed the ultimate responsibility for
the quality of patient care with the
governing board of the hospital. In this
case, an Illinois star athlete’s broken leg
was set improperly by a physician at
the hospital, and the landmark decision
clearly placed the role of oversight
regarding the quality of care on the
board of the hospital.
There was a veritable era of weeding
out poor quality from 1965 to 1990;
peer review systems were established
and quality “assurance” programs
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were created to begin identifying
poor performing physicians in
hospital settings. Additionally, in
1984 Donabedian articulated 7 pillars
of quality that health care providers
must incorporate into their delivery
systems: efficacy, efficiency, optimality,
acceptability, legitimacy, equity, and cost.
Although his paper was a breakthrough
in thinking about improvement of
health care quality, surprisingly few
providers took on the challenge of
developing a systematic approach to
health care quality improvement.
In 1999, the Institute of Medicine
(IOM) published To Error is Human,
which heightened awareness about
human factors that influence health
care delivery and articulated the rate
of errors that occur in a health care
delivery system. In 2001, the IOM
issued a follow-up report, Crossing the
Quality Chasm, which outlined the
aims of medicine and affirmed that
all health care should be safe, timely,
effective, efficient, equitable, and
patient-centered. Three years later, the
National Quality Forum issued a ”call
to responsibility” for health care boards
to understand and accept their roles in
providing oversight of the quality and
safety of health care.
Provider organization governing boards
must thoroughly comprehend this history
to fulfill their fiduciary responsibility.
Transparency and Accountability
Because fiduciary responsibility
has expanded to include not only
the financial health of the provider
organization but also oversight of the
quality of care it provides, boards must
address the business case for improving
quality. The substantial financial costs
of poor quality include complications
(eg, adverse drug events, hospitalacquired infections) that may occur,

adding significant costs to a patient’s
episode of care. Governing boards must
understand that financial improvements
will result when health care providers
practice with “standard work” and
decreased practice variation. Improved
outcomes and better patient experience
lead to a more positive bottom line for
health care organizations.
Today there is increasing emphasis on
transparency and accountability for the
entire spectrum of health care delivery
components. Health care organizations
are expected to share data on the quality
and safety of the care they provide and to
assure that care is delivered in the most
efficient manner. Calls for increased
data transparency have led to health
care organizations being measured on
the quality, safety, and costs of care.
Such data are now publicly available yet another impetus for organizational
transparency and accountability.
Numerous national initiatives to
promote the transparency of quality,
safety, and costs have been implemented:
• I n 2005, Medicare launched a payfor-performance demonstration
program that was modified to
create a “value-based purchasing”
program in 2011. Health care
organizations are now being paid
for quality of care and patient
experience scores. Financial
penalties for poor care (eg, hospital
complications) soon will be
launched by Medicare.
•T
 he Institute for Healthcare
Improvement has rallied for
and modeled the use of data
transparency to leverage and
transform quality and patient safety.
•T
 he newest initiative from Medicare
is the Partnership for Patients
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campaign to reduce both harm and
avoidable rehospitalizations.
These initiatives emphasize the
urgency of and create the platform
for early organizational adoption
and integration that ultimately will
help attain the desired results improved quality and patient safety
and lower costs. With additional
insight, governing boards will begin
to anticipate issues and continually
incorporate quality, safety, and
efficiency outcomes into the
organization’s infrastructure and
strategic goals.
Defining Quality
In order to judge the success of the
organizations they serve, boards must
understand how quality is defined and
measured in the context of health care.
Unfortunately, there is no universal
agreement on a succinct definition of
quality or on appropriate measures to
help define health care quality.
Most boards would agree that the purpose
of health care is to decrease morbidity
from disease processes and to improve the
productivity of their community members
through caring for the sick as well as
preventing other illnesses.
A few definitions of quality are worth
exploring.
The IOM defines health care quality
as ”the degree to which health services for
individuals and populations increase the
likelihood of desired health outcomes and
are consistent with current professional
knowledge.” This definition allows
many providers to feel comfortable
with the care they are providing, yet it
lacks specific measures that could lead
to actionable steps to improve health
care quality.
(continued on page 6)
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Donabedian suggested that we think
about health care quality in terms of
3 components: structure, processes,
and outcomes. This is a preferable
approach, incorporating elements that
are more actionable for health care
organizations desiring to improve
health care quality. Structure allows an
organization to assure that it has the
appropriate facilities and equipment
to provide excellent care. Reliable
processes reflect the organization’s ability
to provide evidence-based medicine
and to achieve the outcomes desired.
And finally, outcomes are measured in
terms of importance to the patient (eg,
decreasing morbidity or mortality).
Emerging definitions of health care
quality focus on patient-centered
definitions of quality. A patientcentered definition allows an
organization to look internally at
the kind of care it provides. Patientcentered care is care wherein:
•p
 atients have access to care by
multiple means;
• c are is based on patient needs
and values;
•p
 atients are the source of control;
• t here is shared knowledge and a
free flow of information between
providers and patients;
•d
 ecision making is evidence based
and specific to the patient’s situation;
• s afety is a fundamental attribute of
the organization;
• c are anticipates the patients’ needs.
Finally, we must broaden our
understanding of health care to
encompass “value.” Boards need to

have basic knowledge of how to define
the value of the health care their
organizations deliver to the populations
they serve. In this era of health care
reform, we are called on to appreciate
the impact of health care on the
population and the costs of care for
our communities. With its focus on
value, this contemporary definition of
quality will certainly take boards in new
directions as they consider their fiduciary
responsibility and their approaches to
organizational modeling and operations.
The Board’s Connection
Governing boards have a very significant
role in defining and shaping the
context in which services are delivered
within the organization. The board
oversees infrastructure such as facilities,
medical staff, and the tools necessary
for improvement. The board selects
what processes will be in place, what
services the organization will deliver,
what departments exist, and what kind
of procedures will be done. Importantly,
the board has oversight over all of
the outcomes the health care delivery
system achieves; hence, measuring and
improving these outcomes are a vital
part of the board’s responsibility.
The board must recognize and
acknowledge its role and responsibility
in ensuring quality of care by directing
the creation of a culture of patient
safety within the organization and
supporting the efforts necessary
to achieve clinical excellence. By
becoming educated about the
measures of health care quality and the
improvement science that results from
analysis of data, the board will improve
its oversight of health care quality.
Levers of Governance
To fulfill its responsibilities, the board
can use certain levers of governance
to help the organization achieve its

goals: (1) Mission, (2) Culture,
(3) Performance, (4) Leadership,
(5) Strategy, and (6) Resource allocation.
1. Mission. The hospital’s mission
states the organization’s purpose
and establishes the direction of its
journey. Accountabilities generally
fall into 3 categories for the mission:
quality of care, access to care, and
stewardship. The governing board
has the ability to alter the mission
to provide oversight of these 3
major categories.
2. Culture. The governing board has
the responsibility to assure that the
health care organization’s culture
includes quality among its highest
values and provides the ongoing
resources and support necessary
to fulfill its commitment to health
care quality. The board must
ensure a culture of improvement
and a culture of patient safety
throughout the organization.
3. P
 erformance. Boards must
ensure that the organization
commits to a definition of quality
that addresses the needs of its
stakeholders and that the definition
is operationalized through
performance measures that help its
leaders evaluate the extent to which
the commitment is being fulfilled.
4. Leadership. The board must
ensure that health care quality
is understood by leadership
at both the management and
board levels. Finding the proper
expertise for management and
governance becomes the ultimate
responsibility of the board.
5. S
 trategy. Boards are obligated to
ensure that the organization has
strategies, goals, and performance
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measures in place to foster
performance that both enables and
supports mission achievement.
Because quality and patient safety are
so critical to fulfilling the mission,
the organization’s board has the
responsibility to make sure there is a
strategic plan to improve health care
quality, patient safety, and the overall
value of the health care delivered.

every meeting, the board should
hear how the hospital is progressing
in terms of quality, what barriers
exist to achieving breakthrough
performance, and how the board can
support improvement of health care
quality. A discussion of quality on
the board agenda at every meeting
ensures that it will get equal billing
with other important agenda items.

6. Resource allocation. Boards
often are faced with difficult
decisions and trade-offs between
cost, quality, competitiveness,
and efficiency. Boards must pay
special attention to the appropriate
allocation of resources that will
help to achieve high-quality and
low-cost care. The board must stay
focused on what is important for
the delivery of health care and on
the mission of the organization.

3. Quality planning. The board should
help create a vision for quality as
part of the health care organization’s
long-term measures and goals,
such as target quality measures
(eg, mortality, complications) and
value-based purchasing measures.
The board should review the
organization’s quality plan for
conformity with the overall strategic
plan and should review appropriate
quality measures on a regular basis.

Tactics for Board Engagement in Quality
Four tactics can help the board become
engaged in health care quality: (1)
increasing the quality literacy of the
board, (2) creating an agenda for quality,
(3) quality planning and focus, and (4)
sharing patient-centered stories.

4. Patient-centeredness stories.
Patients’ stories should be shared
with the board at its meetings to
further increase the focus on patientcenteredness. Sharing patient
stories ensures that the board stays
focused on the processes and the
barriers to improving the quality of
care. Positive and negative stories
highlight the importance of the
many quality initiatives going on
throughout the organization.

1. L
 iteracy. The board must become
educated on salient issues regarding
quality beyond those related to
public reporting. A quality expert
should sit on the board to help
initiate and lead discussions about
what defines health care quality.
Board retreats offer opportunities
for in-depth dialogue on quality
and safety projects. Finally, board
members should attend national
health care conferences.
2. Frame an agenda. The board chair
and the chief executive officer
should meet to discuss the status
of quality in the organization. At

Tasks to Improve Quality
There are 4 specific tasks involved in
improving the quality of care:
1. E
 stablishing culture. Boards should
ensure that management has an
understanding of safety that includes
training in systems thinking as
well as in improvement science.
Organizations that use human
factors to help design processes
have better results and better care.
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Board members can participate in
promoting a culture of safety by
walking around the organization
with management, focusing in on
errors, teamwork, and transparency
so that everyone sees the goals of
creating a culture of safety.
2. Establishing performance goals.
Boards must set specific performance
goals for the organization. Some
boards use the IOM aims (ie, safety,
timeliness, effectiveness, efficiency,
equity, patient-centeredness) to
help decide upon measures for their
organizations. Newer measures to
evaluate the health care delivery
system’s impact on improving
population health, per capita costs,
and patient experience also could
be used. The data must be readily
available and used on a regular
basis to help drive improvement.
Accountability for these performance
goals must be incorporated into
management’s responsibilities.
3. P
 romoting leadership collaboration.
Boards must ensure that
management and physicians
are collaborating to achieve
improvements in quality, patient
safety, and value. The medical
staff must be engaged in health
care quality and its leaders must
be committed to establishing
a culture of improvement and
safety for the organization. These
medical staff leaders must be able
to work in a multidisciplinary
fashion with management teams to
create “standard work,” to decrease
practice variation, and to improve
health care quality.
4. E
 mpowering a Quality Committee
Finally, the board should establish
an independent governance
committee to oversee quality of
(continued on page 8)

This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC.

8

Prescriptions for Excellence in Health Care

care. The Quality Committee must
be multidisciplinary, involving
physicians, nurses, and board
members as well as experts in
improvement. Oversight of the
Quality Committee includes
performance improvement, clinical
outcomes, patient satisfaction, and
patient safety. Literacy in health
care quality, patient experience,
and measurement are required
for members of the Quality
Committee. The health care
Quality Committee should demand
total transparency throughout the
organization and use performance
data to help drive improvement.
Conclusions
There are new levels of transparency and
accountability in health care delivery
today. Governing boards have a specific
call to responsibility in providing oversight
of the quality of care that the organization
delivers. There are specific levers of
governance that boards can use to help

improve health care quality and there are
specific tasks that a board can employ
to improve the oversight of health care
quality. As health care organizations move
forward in the era of health care reform,
understanding the value that health care
organizations provide with regard to
improving population health in a costeffective manner will become paramount
to the role of governing boards.
Evan M. Benjamin MD, FACP, is Senior
Vice President and Chief Quality Officer
for Baystate Health, Inc., in Springfield,
MA, and Associate Professor of Medicine at
Tufts University School of Medicine,
as well as a member of the Board of
Trustees of Catholic Health Partners,
Cincinnati, OH. He can be reached at:
Evan.Benjamin@baystatehealth.org
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The Journey to Better Governance: Board Education, Competencies, and Self-Assessment
By Sean Patrick Murphy, Esq.
It is no secret that governing boards including hospital and health systems
boards - are under enormous pressure to
become more accountable and effective.
Good governance is a challenge for
hospitals and health systems as they
continue to transform themselves in
response to these pressures. The role of
the governing board is oftentimes unclear
in this challenging environment. This
article will examine 3 recent governance
trends that can make a difference in
building a better board: notably, (1)
the movement toward “formal board
education” programs, (2) the concept of
director and board competencies, and

(3) the increasing demand for board and
director assessment.
Board Education
Today, everyone understands the value
and importance of board education,
especially in the exceedingly complex
health care industry. However, the
demand for “accountable governance”
has driven many stakeholders and
governing boards to go further by
pursuing formal board education
programs. By 2011, eleven state hospital
associations had instituted some form
of voluntary, formal board education
program for hospital boards and

directors. New Jersey passed legislation
requiring that directors and trustees of
hospital boards receive 7 hours of formal
board education as a legal requirement
and condition for serving on a hospital
board. Since then, Delaware, Arkansas,
and South Carolina state hospital
associations have implemented formal
board training programs for their
hospital trustees and directors.
Why the trend toward formal board
education? Some might argue that
it provides a baseline for educational
competency, demonstrating to
stakeholders that the hospital’s directors
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and boards have taken the time to
complete formal training and education.
Others might argue that a voluntary
state hospital association initiative could
possibly help to ward off potential
legislation that would mandate it, as
was the case in New Jersey. Finally, as
the vast majority of hospital directors
and trustees are volunteers who serve
without compensation, it can be said
that there are many who pursue such
programs in the spirit of service.
These programs are not without their
critics. Many state associations appear
to be opting out of formal certificate/
certification programs because they
believe that the programs are not
sufficiently rigorous or that they
provide a false sense of competency
and achievement. Clearly, health care
governing boards need - and will continue
to need - plenty of education, especially
in light of the many upcoming changes
to the payment delivery system. However,
the jury is still out as to whether these
state association initiatives will prove to
be a definitive vehicle for establishing
board educational competency, or
whether they will need to do more.
The truth is that the educational needs
of governing boards are not likely to
be satisfied merely through certificate
programs. Health care is complex, and
each director and governing board
is unique. Although these certificate
programs arguably could provide some
core training for boards, they need
much more.
Board education programs should be
aligned with comprehensive board
orientation programs. Such programs
acquaint new directors not only with
health care in general but also with the
organization they will be governing,
including market dynamics and
upcoming changes in the delivery

system (ie, health reform). Further, a
recent governance report published by
the Alliance for Advancing Nonprofit
Healthcare suggested that governing
boards conduct individual director
educational assessments to target
specific needs and opportunities
to enhance board knowledge and
performance through education.
Competent and Qualified to Govern
Another emerging issue is board
competencies (ie, assessing whether
governing boards and individual
directors are competent and qualified
to govern). In 2009, the American
Hospital Association (AHA) Center for
Healthcare Governance’s Blue Ribbon
Report ultimately defined competency
as the combination of knowledge, skills,
personal characteristics, and individual
social behaviors needed to effectively
perform a job.
A closely related concept is whether
a governing board is “qualified” to
govern. In February 2010, the Securities
Exchange Commission (SEC) issued
a new series of regulations on director
qualifications for publically traded
companies. The SEC regulations require
that corporations disclose to shareholders
biographical information about directors
and nominees so that shareholders may
determine whether directors have the
requisite qualifications to govern.
Although competency-based governance
continues to gain acceptance as an
important standard of governance,
health care organizations have been
slow to react. In fact, a 2011 AHA
Center for Healthcare Governance
report indicates that the vast majority
of health care governing boards are
not employing “competency-based”
governance standards. Further, and
perhaps more troubling, is that those
health care organizations that do employ
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competency-based tools continue to rank
finance and strategic visioning as the “top
2” competencies—with patient safety
and quality rating a distant fifth place.
In an age of increasing transparency,
hospitals and health systems are well
advised to take standards for board
competencies and qualifications
more seriously. Further, as health
care migrates from fee for service to
population health, hospitals and health
systems would be well advised to gain
substantial expertise in quality and
safety as this will be the foundation for
both payment and performance in our
new value-based system of health care.
Board and Director Evaluation
and Assessment
A final area of increasing importance is
evaluation and assessment, particularly
individual director assessment.
Feedback is essential for both personal
and professional growth and maturity.
This is true for the governing board. A
2010 Governance Institute study revealed
that the vast majority of directors and
chief executive officers believed that
feedback about individual director
performance would help improve
governance and help build a better board.
Yet, a 2011 AHA Center for Healthcare
Governance survey indicated that most
boards are far off the mark. Fewer than
25% of those surveyed indicated that
individual board members conducted
self-assessments and that fewer than 3%
conducted peer-to-peer assessments.
In this instance, there is wide disparity
between what boards and directors
think they should do to become better
boards and what they actually do. This
is not surprising as most hospital and
health system directors and boards
are volunteers, and those who are
compensated receive fairly negligible
(continued on page 10)
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remuneration for the time they spend
and the responsibilities they bear. Under
these circumstances, some directors
might find it disconcerting to have their
behavior and performance evaluated by
others, including their peers. However,
this need not be the case.
Communication is at the heart of
evaluation and assessment. The purpose
of assessment is to strengthen the board
by providing helpful, productive feedback
that will not only build a better board but
also will enable directors to maximize their
capacity and potential to be contributing,
effective board members. There are many
tools and techniques that boards can
employ to accomplish these goals without
imputing a harsh, hypercritical evaluation
technique. Further, if done properly, each
director should be given the opportunity

to comment on the board itself to help
build a better, more effective board and to
help keep directors involved, interested,
and engaged.
Conclusion
We are moving away from an era
in which boards and directors were
merely “presumptively qualified”
by their resumes (ie, their training,
education, experience) and moving
toward a model of board accountability
and effectiveness. Board education,
competencies, and qualifications, and
board and director assessment are 3
areas that hospitals and health system
governing boards can embrace to meet
the challenges of changing systems of
governance. The opportunity exists to
build highly effective and accountable
health care governing boards.

Sean Patrick Murphy, Esq., is Senior
Vice President, Corporate General
Counsel, and Assistant Secretary to Solaris
Health System. He can be reached at:
SMurphy@JFKHealth.org.
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Pioneering at the Trust Frontier: The Expanded Role of Governance in ACOs
By Nathaniel Foote, JD, MBA
Accountable Care Organizations
(ACOs) are at the heart of initiatives to
reform health care delivery under the
Affordable Care Act (ACA). ACOs are
designed to move payment structures
beyond the perverse incentives of “fee
for service.” They build in rewards for
delivering more efficient, high-quality
care by creating accountability for a
specific patient population and sharing
in the savings derived from delivering
care to that population.
Although some ACOs are fully
integrated delivery systems governed
by a single board, they were explicitly
designed as a construct to bring together
multiple corporate entities to function as
an integrated system of care. This article
focuses on the implications of this multientity construct for board governance, and
elaborates on the following propositions:

• I n bringing together multiple
corporate entities to act as part of an
integrated system, ACOs create an
expanded role for governance.

is accountable for the care delivered
to a population of patients and that
provides a mechanism to receive and
distribute payments for shared savings.

•T
 he dual demands on ACOs
for both cost and quality create a
strengthened imperative for effective
board oversight of care quality.

Historically, there have been various
legal barriers to coordination across
independent provider entities.
Implementation of the ACA explicitly
sought to address these; for example,
providing ACOs with waivers of the
application of the Physician SelfReferral Law, the Federal antikickback
statute, and applying a “rule of
reason” antitrust test (rather than
per se illegality) for price setting and
market allocation agreements among
competing providers who participate
in an ACO, including explicit support
for risk-sharing arrangements that
promote efficiency.

•T
 o succeed, ACO boards will
need to embrace responsibility
for developing and overseeing an
aligned, high-commitment, hightrust system of care for patients.
Multi-entity ACOs Expand the Role of
Board Governance
ACOs create a formal legal structure
that enables “shared governance”
so that multiple corporate entities
function as a coordinated system that
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With these barriers removed, the
challenge for ACOs is to develop an
organizing approach that achieves
effective coordination and integration
across entities to optimize patient
outcomes. To the extent that multiple
institutions are involved, each with
its own governing board, the required
integration of decision making and
cross-boundary coordination cannot rely
on a single hierarchical line of authority,
because the line of accountability
within each institution runs from its
administrative and clinical leadership
to its own board. Instead, achieving
effective coordination and integration
depends on an expanded governance
role for the ACO board. Specifically,
the accountability of constituent entity
boards to the ACO board serves as the
basis for the administrative and clinical
leadership of the ACO to provide
direction to the enterprise. Figure 1
illustrates how the authority of ACO
leadership is derived from that of the
ACO board in a multi-entity structure.
Dual ACO Responsibility for Cost and
Quality Creates a Strengthened Imperative
for Effective Quality Oversight
Although enhancing the effectiveness
of board oversight of the quality and
safety of patient care has been a major
focus in health care for nearly a decade,
the imperative for ACO boards is
even greater. With powerful incentives
to reduce costs, ACOs will be under
heightened scrutiny from patients
and other observers for any signs that
they are sacrificing quality to cut costs.
Indeed, the ACA invited such scrutiny
by including stringent requirements
around transparency of ACO
performance on both quality and patient
satisfaction dimensions.
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the Department of Health and Human
Services noted in promulgating the
final rule implementing ACOs under
the ACA, “Many commenters were
concerned that the Shared Savings
Program has similar characteristics to
some forms of managed care where it
is possible to achieve savings through
inappropriate reductions in patient care.”

•A
 n effective system design and
corresponding funds flows to align
incentives around providing highquality, cost-effective care.

It follows that ACO boards must
understand that ensuring unimpeachable
quality and safety of patient care is
central to their institutional mission
and viability, and is necessary to ensure
patient confidence in the integrity of the
ACO’s clinical decision making.

System Design to Align Incentives
The board has ultimate responsibility
for the design of the system of care, so
as to enable and reinforce appropriate
patient referral flows and clinical
decision making. Key elements include
the effective design of accountability
units and their corresponding funds flow
to provide incentives to optimize “Triple
Aim” outcomes.

Board Governance Role in Ensuring HighTrust, High-Commitment Systems of Care
In addition to a strong focus on quality,
a multi-entity ACO board must
play an expanded role in overseeing
the effectiveness of the care delivery
system, ensuring:

•A
 shared culture and commitment
to a common purpose of effective
patient care that enables effective
cross-boundary collaboration.

Board focus on system design is
particularly important because of the
fundamental shifts in relative bargaining
power that the move to a patient

Figure 1. ACO Board Authority Sets the Context for Effective Executive Leadership
in Multi-Entity Systems

In particular, ACOs must overcome the
legacy from our earlier experience with
health maintenance organizations. As
(continued on page 12)
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population perspective is likely to set in
motion. Patient care likely will become
more primary care centered, with funds
flow models that increasingly treat the
primary care practice as accountable for
”Triple Aim” outcomes for it’s patients
and, specifically, total medical expense.
Conceptually, primary care will become
the purchaser of services from specialty,
hospital, and ancillary services. To the
extent this occurs, it will put significant
pressure on specialists, who become
cost centers rather than profit centers,
and on shifting care out of higher cost
tertiary institutions into more costeffective community hospitals.
The ACO board may well be
confronted by constituent entities
that are more focused on protecting
legacy positions and assets than on
the optimal design for the future, and

will need to be actively involved in
negotiating a viable path.
Culture and Commitment to the Purpose
of Patient Care
In addition to ensuring aligned
accountabilities and financial incentives
for effective system functioning, ACO
boards also will need to focus attention
on promoting a shared culture and
mind-set among system participants
to enable effective collaboration across
entity boundaries.
ACO Boards will need to appreciate that
the enterprise is both an economic entity
and a social institution in which individual
providers’ sense of affiliation and
commitment is shaped by the extent to
which they believe there is a meaningful
common purpose and a community of
colleagues with whom they identify.

Multi-entity ACOs represent an attempt
to gain the benefits of functioning as an
integrated system without moving to
full asset merger. The paradox for these
ACOs is that what they are trying to do
is harder than functioning within a single
system; therefore, they must work harder
on mind-set, trust, and commitment –
starting with the ACO board.
Whether multi-entity ACOs represent an
approach that is viable over the long run,
or simply a transitional stage to greater
consolidation of integrated systems, will
depend heavily on how effectively ACO
boards are able to address the governance
challenges highlighted in this article.
Nathaniel Foote, JD, MBA, is Managing
Director of TruePoint. He can be reached
at: nfoote@truepoint.com.
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